吸入性糖皮质激素治疗成年人和青少年哮喘疗效和副作用的Meta-分析(3)
 |
| 第1页 |
参见附件(2986KB，4页)。
[4] Pearlman D.S， Berger WE， Kerwin E， et al. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma.J Allergy Clin Immunol,2005,116(6)：1206.
[5] Langdon C.G， Adler M， Mehra S， et al.Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma.Respir Med,2005,99(10)：1275-1285.
[6] Chapman K.R，Patel P，D Urzo AD，et al.Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.Allergy,2005,60(3)：330-337.
[7] Baumgartner R.A，Martinez G，Edelman JM，et al.Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.Eur Respir J,2003,21(1)：123-128.
[8] Yurdakul A.S，Taci N，Eren A，et al.Comparative efficacy of once-daily therapy with inhaled corticosteroid，leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.Respir Med，2003，97(12)：1313-1319.
[9] Riccioni G，Vecchia RD，D’Orazio N，et al.Comparison of montelukast and budesonide on bronchial reactivity in subjects with mild-moderate persistent asthma ......
您现在查看是摘要介绍页，详见PDF附件(2986KB，4页)。